Literature DB >> 17336997

Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein.

Nileena Velappan1, Jennifer S Martinez, Rosa Valero, Leslie Chasteen, Liana Ponce, Virginie Bondu-Hawkins, Craig Kelly, Peter Pavlik, Brian Hjelle, Andrew R M Bradbury.   

Abstract

Rodent-borne hantaviruses cause hemorrhagic fever with renal syndrome (HFRS) in the old world and hantavirus cardio-pulmonary syndrome (HCPS) in the new. Most cases of HCPS in North America are caused by Sin Nombre Virus (SNV). Current viral detection technologies depend upon the identification of anti-viral antibodies in patient serum. Detection of viral antigen may facilitate earlier detection of the pathogen. We describe here the characterization of two single-chain Fv antibodies (scFvs), selected from a large naïve phage antibody library, which are capable of identifying the Sin Nombre Virus nucleocapsid protein (SNV-N), with no cross reactivity with the nucleocapsid protein from other hantaviruses. The utility of such selected scFvs was increased by the creation of an scFv-alkaline phosphatase fusion protein which was able to directly detect virally produced material without the need for additional reagents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336997     DOI: 10.1016/j.jim.2007.01.011

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Phage-displayed combinatorial peptide libraries in fusion to beta-lactamase as reporter for an accelerated clone screening: Potential uses of selected enzyme-linked affinity reagents in downstream applications.

Authors:  Girja S Shukla; David N Krag
Journal:  Comb Chem High Throughput Screen       Date:  2010-01       Impact factor: 1.339

2.  Healthy humans can be a source of antibodies countering COVID-19.

Authors:  Nileena Velappan; Hau B Nguyen; Sofiya Micheva-Viteva; Daniel Bedinger; Chunyan Ye; Betty Mangadu; Austin J Watts; Robert Meagher; Steven Bradfute; Bin Hu; Geoffrey S Waldo; Antonietta M Lillo
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 3.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

4.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

5.  The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.

Authors:  Ann R Hunt; Shana Frederickson; Toshiaki Maruyama; John T Roehrig; Carol D Blair
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

6.  Development of phage-based single chain Fv antibody reagents for detection of Yersinia pestis.

Authors:  Antonietta M Lillo; Joanne E Ayriss; Yulin Shou; Steven W Graves; Andrew R M Bradbury; Peter Pavlik
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

7.  Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding.

Authors:  Sara D'Angelo; Fortunato Ferrara; Leslie Naranjo; M Frank Erasmus; Peter Hraber; Andrew R M Bradbury
Journal:  Front Immunol       Date:  2018-03-08       Impact factor: 7.561

Review 8.  Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.

Authors:  Tobias Unkauf; Sebastian Miethe; Viola Fühner; Thomas Schirrmann; André Frenzel; Michael Hust
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

9.  Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV).

Authors:  Martina Inga Kirsch; Birgit Hülseweh; Christoph Nacke; Torsten Rülker; Thomas Schirrmann; Hans-Jürgen Marschall; Michael Hust; Stefan Dübel
Journal:  BMC Biotechnol       Date:  2008-09-02       Impact factor: 2.563

Review 10.  Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.

Authors:  Philipp Kuhn; Viola Fühner; Tobias Unkauf; Gustavo Marcal Schmidt Garcia Moreira; André Frenzel; Sebastian Miethe; Michael Hust
Journal:  Proteomics Clin Appl       Date:  2016-06-21       Impact factor: 3.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.